K241490 is an FDA 510(k) clearance for the Contour+ (MVision AI Segmentation). Classified as Radiological Image Processing Software For Radiation Therapy (product code QKB), Class II - Special Controls.
Submitted by Mvision AI OY (Helsinki, FI). The FDA issued a Cleared decision on October 18, 2024 after a review of 147 days - within the typical 510(k) review window.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.
View all Mvision AI OY devices